
|Articles|February 21, 2005
Psoriasis treatment advances
There has been a boon in advances for the treatment of psoriasis, spanning an arsenal of new biologic therapies. As a group, biologics are already the most prescribed systemic medications for the treatment of psoriasis, according to Mark Lebwohl, M.D., Mount Sinai School of Medicine, New York City, who discussed many on the market.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















